NPM1, Mouse anti-Human, Clone: NPM1/1902, Novus Biologicals™

NPM1

Monoclonal

0.2 mg/mL

Western Blot 1-2 ug/ml, ELISA 2-4 ug/ml, Immunohistochemistry 1-2 ug/ml, Immunohistochemistry-Paraffin 1-2 ug/ml, Protein Array

P06748, P06748

NPM1

Recombinant human NPM1 protein fragment (aa185-287) (exact sequence is proprietary)

100 μg

Apoptosis, Cancer, Cell Cycle and Replication, Chromatin Research, DNA replication Transcription Translation and Splicing, Mitotic Regulators, Phospho Specific, Signal Transduction, Tumor Suppressors

4869

Human

Purified

Western Blot, ELISA, Immunohistochemistry, Immunohistochemistry (Paraffin), Peptide Array

NPM1/1902

Unconjugated

10 mM PBS with 0.05% BSA

B23, MGC104254, NPMnucleophosmin/nucleoplasmin family, member 1, Nucleolar phosphoprotein B23, Nucleolar protein NO38, nucleophosmin, nucleophosmin (nucleolar phosphoprotein B23, numatrin), numatrin

Mouse

Protein A or G purified

RUO

Primary

This antibody recognizes a 33kDa glycoprotein, identified as Nucleophosmin (NPM1). It is predominantly localized in the nucleus of cells in most tissues. NPM1 is involved in ribosomal assembly and rRNA transport. It is an abundant protein that is highly phosphorylated by Cdc2 kinase during mitosis. This phosphoprotein moves between the nucleus and the cytoplasm. It is thought to be involved in several processes including regulation of the ARF/p53 pathway. A number of genes are fusion partners, in particular the anaplastic lymphoma kinase gene on chromosome 2. Mutations in exon 12 affecting the C-terminus of the protein are associated with an aberrant cytoplasmic location. Mutations in this gene are associated with acute myeloid leukemia. The antibody may be a useful aid for classification of acute myeloid leukemia.

Store at 4°C.

IgG2b κ